Pilot Study of IMRT for Ovarian Cancer
Author Information
Author(s): Rochet Nathalie, Jensen Alexandra D, Sterzing Florian, Munter Marc W, Eichbaum Michael H, Schneeweiss Andreas, Sohn Christof, Debus Juergen, Harms Wolfgang
Primary Institution: University of Heidelberg
Hypothesis
Can intensity-modulated radiation therapy (IMRT) improve the feasibility and reduce toxicity of whole abdominal irradiation (WAI) in high-risk stage III ovarian cancer patients?
Conclusion
The study aims to evaluate the feasibility and toxicity of IMRT for whole abdominal irradiation in patients with advanced ovarian cancer.
Supporting Evidence
- Ovarian cancer has a poor prognosis, with over 60% of patients developing recurrent disease.
- Whole abdominal irradiation has been shown to be effective but is underused due to high toxicity.
- IMRT may reduce toxicity while effectively treating the peritoneal cavity.
Takeaway
This study is testing a new way to give radiation therapy to help women with advanced ovarian cancer while trying to avoid hurting their healthy organs.
Methodology
Single center pilot trial of a phase I/II study treating patients with advanced ovarian cancer stage FIGO III using IMRT for whole abdominal irradiation.
Limitations
The study is limited to a small sample size of 8 patients, which may not provide conclusive evidence.
Participant Demographics
Patients aged 18 to 75 with histologically confirmed ovarian cancer stage FIGO III and specific health criteria.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website